| Literature DB >> 16510280 |
Robert M Strieter1, Marie D Burdick, Javier Mestas, Brigitte Gomperts, Michael P Keane, John A Belperio.
Abstract
Chemokines have pleiotropic effects in regulating immunity, angiogenesis, stem cell trafficking, and mediating organ-specific metastases of cancer. In the context of angiogenesis, the CXC chemokine family is a unique group of cytokines known for their ability to behave in a disparate manner in the regulation of angiogenesis. The glutamic acid-leucine-arginine (ELR+) CXC chemokines are potent promoters of angiogenesis, and mediate their angiogenic activity via signal-coupling of CXCR2 on endothelium. By contrast, members of the CXC chemokine family, such as platelet factor-4 (PF4; CXCL4) and interferon-inducible CXC chemokines are potent inhibitors of angiogenesis, and use CXCR3 on endothelium to mediate their angiostatic activity. This review will discuss the biology of CXC chemokines in the context of angiogenesis related to cancer.Entities:
Mesh：
Substances：
Year: 2006 PMID： 16510280 DOI： 10.1016/j.ejca.2006.01.006
Source DB: PubMed Journal: Eur J Cancer ISSN： 0959-8049 Impact factor: 9.162